In the phase 4 FOREMOST trial, treatment with apremilast improved both clinical and patient-reported outcomes at week 16 among patients with early oligoarticular PsA.

Biosimilars are safe, effective, and well-tolerated for psoriasis treatment, providing significant cost savings for the ...

Oral Opportunity in PsO (US) 2024, highlights a shifting landscape in the treatment for moderate-to-severe PsO. As emerging oral therapies gain traction, the study underscores their potential to ...

Despite uncertainty around who will sit in The White House in January and what ramifications they may bring, the industry’s ...

If you have arthritis, you know how painful it can be, and the older you get, the more likely you are to have problems. There ...

Patients with rheumatoid arthritis, an inflammatory disorder known for causing joint pain and reducing mobility, pay an ...

Hello Health Rounds Readers! We know a lot of you struggle with arthritis knee pain and today we feature a report that could ...

A global team of researchers at the Max Planck Institute of Biochemistry has made a discovery that has helped save the lives ...